Federal Register of Legislation - Australian Government

Primary content

Continence Aids Payment Scheme 2010

Authoritative Version
  • - F2010L01708
  • In force - Superseded Version
  • View Series
Schemes as made
This instrument provides the Continence Aids Payment Scheme under which the Commonwealth makes payments as a contribution towards the cost of buying products that help manage incontinence.
Administered by: Health
Registered 30 Jun 2010
Tabling HistoryDate
Tabled HR28-Sep-2010
Tabled Senate28-Sep-2010

 

 

Continence Aids Payment Scheme 2010



I, JUSTINE ELLIOT, Minister for Ageing, formulate this Scheme under section 12 of the National Health Act 1953.

Dated  __28 June____ 2010

 

 

Justine Elliot

____________________________________

Minister for Ageing



 

 

 

 

 

 

 


Contents

 

 

Part 1                   Preliminary                                                                                           3

1.           Name of Scheme                                                                                     3

2.           Commencement                                                                                      3

3.           Interpretation                                                                                           3

Part 2                   Participation in the Scheme                                                                 5

4.           Eligibility criteria                                                                                      5

5.           Application to participate in the Scheme                                                    5

6.           Notification to Medicare Australia CEO                                                      6

7.           Decision that a person has ceased to be eligible                                        6

8.           When participation ceases to have effect                                                   7

Part 3                   Payments                                                                                              8

9.           Amount of CAPS payment                                                                       8

10.          Payment procedure                                                                                 8

11.          Payment by instalments                                                                          8

12.          Payment to transferred person                                                                  9

13.          Payment to approved person                                                                   10

14.          Notification of details of payments                                                           10

Part 4                   Representatives and organisations                                                     11

15.          Interpretation                                                                                         11

16.          Ceasing representation of a person                                                          11

17.          Authorised representative                                                                       11

18.          Correspondence recipient                                                                       12

19.          Authorised payment recipient                                                                  12

20.          Responsible person for a participating person                                           12

21.          Organisations authorised to receive CAPS payments                                13

Part 5                   Miscellaneous                                                                                     15

22.          Debts                                                                                                   15

23.          Investigations                                                                                        15

24.          Review of decisions                                                                                15

Schedule                                                                                                                         16

 


Part 1        Preliminary

1.                      Name of Scheme

This Scheme is the Continence Aids Payment Scheme 2010.

2.                      Commencement

This Scheme commences on 1 July 2010.

3.                      Interpretation

(1)        In this Scheme:

Act means the National Health Act 1953.

Amendment Act means the National Health Amendment (Continence Aids Payment Scheme) Act 2010.

approved form, when used in a provision of this Scheme, means a form approved, whether before or after the commencement of this Scheme, by the Secretary or Medicare Australia CEO in writing for the purposes of that provision.

authorised payment recipient, for a participating person, means the person referred to subsection 19(3).

authorised representative means a person referred to in subsection 17(3).

CAPS payment, for a participating person, means:

(a)                    for a financial year—the amount specified in subsection 9(1); or

(b)                   for part of a financial year—the amount calculated in accordance with, subsection 9(2).

continence aid means a product intended to assist in the management of incontinence and, for the avoidance of doubt, includes continence-related products.

correspondence recipient means a person referred to in section 18.

eligibility criteria has the meaning given by section 4.

eligible neurological condition means a condition listed in Part 1 of the Schedule.

eligible other condition means a condition listed in Part 2 of the Schedule.

health professional means:

(a)                    a person engaged in a health care related vocation or profession who must be registered or licensed (however described) under a Commonwealth, State or Territory law in order to practise that vocation or profession; or

(b)                   a person who is an eligible Aboriginal health worker under the Health Insurance (Allied Health Services) Determination 2009 made under the Health Insurance Act 1973.

Note:  Section 10 of the Acts Interpretation Act 1901 deals with references to legislation that has been amended or replaced.

legal representative means a person with legal authority under a law of a State or Territory to act for another person such as a guardian or attorney under a power of attorney.

organisation means an entity, including a body politic, with an Australian Business Number which provides, will provide or will facilitate the provision of continence aids to a participating person, but does not include a person:

(a)                    with legal authority under a law of a State or Territory to act for the applicant or participating person; or

(b)                   a person referred to in paragraphs 17(2)(a) to (c) or 19(1)(a) to (c).

participating person means:

(a)                    a person approved under section 5 to participate in this Scheme; or

(b)                   a person taken to participate, and to be eligible to participate, in this Scheme under item 3 of the Amendment Act,

unless the person’s participation has ceased to have effect under this Scheme.

Note:  Item 3 of the Amendment Act and section 8 of this Scheme deal with when a person’s participation ceases to have effect.

permanent and severe incontinence means frequent and uncontrollable moderate to large loss of urine or faeces which impacts on a person's quality of life and which is unlikely to improve with medical, surgical or clinical treatment regimes.

Secretary includes a person authorised by the Secretary to act on his or her behalf in approving forms for, or related to, this Scheme.

(2)        Nothing in this Scheme is intended to affect the operation of any law of a State or Territory that deals with legal representatives.

(3)        References to a legal representative in particular provisions and not in others is not intended to limit a legal representative’s powers to act for the represented person.

Part 2        Participation in the Scheme

4.                      Eligibility criteria

(1)        The eligibility criteria for a person to participate in this Scheme is that the person:

(a)                    suffers from permanent and severe incontinence:

(i)                      caused by an eligible neurological condition; or

(ii)                     caused by an eligible other condition and the person has a Centrelink Pensioner Concession card or entitlement, whether as primary cardholder or a dependant of a cardholder; and

(b)                   is an Australian citizen or permanent resident within the meaning of those terms in the Australian Citizenship Act 2007; and

(c)                    is not ineligible because of subsection (2).

Note:   Item 3 of the Amendment Act provides that a person who was receiving assistance under the Continence Aids Assistance Scheme immediately before 1 July 2010 is taken to participate in this Scheme from 1 July 2010 subject to complying with that section and, after 30 June 2011, meeting the eligibility criteria in this section.

(2)        A person in any of the following categories is not eligible to participate in this Scheme:

(a)                    (for the avoidance of doubt) people who suffer from transient, rather than permanent and severe, incontinence;

(b)                   children under 5 years of age;

(c)                    care recipients, under the Aged Care Act 1997:

(i)                      where the approved provider is providing the care recipient with a high level of residential care and receiving a subsidy in respect of the care recipient for that level of care; or

(ii)                     who are receiving an Extended Aged Care at Home (EACH) or Extended Aged Care at Home Dementia (EACHD) package and the care recipient’s care plan includes continence products;

(d)                   people eligible to receive assistance for continence aids under the Rehabilitation Appliances Program (or replacement program if the name of that program is changed) through the Department of Veterans' Affairs;

(e)                    Australian citizens or permanent residents who have resided outside Australia for a continuous period of three years (including any periods of leave from the country in which that person resides);

(f)                     a person serving a prison sentence.

5.                      Application to participate in the Scheme

(1)        A person may apply to the Medicare Australia CEO to participate in this Scheme.

(2)        The Medicare Australia CEO must approve a person to participate in this Scheme if:

(a)                    the applicant meets the eligibility criteria; and

(b)                   the application is made on the approved form; and

(c)                    the application:

(i)                      includes a statement prepared and signed by a health professional certifying that the applicant has been diagnosed by a doctor with an eligible neurological condition or eligible other condition, as the case may be, which has caused permanent and severe incontinence; and

Note:  Health professional is defined in subsection 3(1).

(ii)                     includes any other document or information required by the approved form.

Note:  Section 14 of the Amendment Act provides that if an application is refused the Medicare Australia CEO must give the applicant a signed notice that includes the reasons for the decision and advising that the person may apply to the Medicare Australia CEO for a review of the decision.  The application for review of the decision is dealt with in section 24 of this Scheme.

(3)        If a person has provided a completed application, in the approved form, to the Medicare Australia CEO before this Scheme commences, the application is taken to have been made under this section on the day this Scheme commences.

6.                      Notification to Medicare Australia CEO

(1)        A participating person, legal representative or authorised representative must notify the Medicare Australia CEO promptly on becoming aware that the participating person does not meet the eligibility criteria.

Example:   A participating person must notify the Medicare Australia CEO if the person begins receiving a high level of residential care in a residential care facility:  see subparagraph 4(2)(c)(i).

(2)        A legal representative or authorised representative must notify the Medicare Australia CEO promptly on becoming aware that the participating person has died.

7.                      Decision that a person has ceased to be eligible

If notification has not been given under subsection 6(1), but the Medicare Australia CEO is satisfied that a participating person does not meet the eligibility criteria, the CEO must decide, by determination in writing, that the person is not eligible to participate in this Scheme and the date on which the person ceased to be eligible.

Note 1:  Item 3 of the Amendment Act provides that, until 1 July 2011, the Medicare Australia CEO cannot make a decision about ineligibility in respect of a person to whom that item applies.

Note 2:   Section 15 of the Amendment Act provides that if the Medicare Australia CEO decides that a participating person is not eligible to participate in the scheme, he or she must give the person a signed notice that includes the reasons for the decision and advising that the person may apply to the Medicare Australia CEO for a review of the decision.  The application for review of the decision is dealt with in section 24 of this Scheme.

8.                      When participation ceases to have effect

A person’s participation in this Scheme ceases to have effect:

(a)                    if notification is given under paragraph 6(1)─from the date the person ceased to meet the eligibility criteria; or

(b)                   if the Medicare Australia CEO decides that the person is not eligible to participate─from the date specified in the determination under section 7.

Note:   Where a person entitled to a CAPS payment has died, payment will be made to the estate:  see paragraph 10(1)(c).

Part 3        Payments

9.                      Amount of CAPS payment

(1)        The amount of the CAPS payment for a financial year is $497.79.

(2)        However, if a person is approved under section 5 as a participating person after the beginning of a financial year, the CAPS payment for the person for that financial year is calculated on a pro rata basis, being the period starting on the date the application under section 5 was received and ending on 30 June (inclusive) of the financial year.

Example:  A person applies on 1 August 2010.  The person’s CAPS payment is calculated for the period 1 August to 30 June 2011 (inclusive).

(3)        A participating person may not receive:

(a)                    more than the amount of the CAPS payment for a financial year in any one financial year;

(b)                   more than one payment for the same period in a financial year.

10.                  Payment procedure

(1)        The Medicare Australia CEO must pay a CAPS payment, or an instalment of a CAPS payment, to which a participating person has become entitled under this Scheme to:

(a)                    the person; or

(b)                   if there is an authorised payment recipient for the person─the authorised payment recipient; or

(c)                    if the person has died, the person’s estate.

(2)        The CAPS payment must be made:

(a)                    in one transaction unless the person has elected, in the approved form, to receive the payment in two instalments (except where subsection 11(4) applies); and

(b)                   by way of electronic funds transfer to the bank account notified, in the approved form, to the Medicare Australia CEO.

11.                  Payment by instalments

(1)        A person may elect to receive the CAPS payment in two instalments, worked out in accordance with this section, in a financial year.

(2)        If the person is a participating person on 1 July in the financial year:

(a)                    the first instalment is half of the CAPS payment specified in subsection 9(1), to be paid no later than 30 July in the financial year; and

(b)                   the second instalment is the remaining half of the CAPS payment, to be paid on or after 1 January but no later than 31 January in the financial year.

(3)        If an application under section 5 is received after 1 July but before 1 January in the financial year and is approved, the CAPS payment for the financial year is the amount calculated in accordance with subsection 9(2) with:

(a)                    the first instalment a pro rata amount calculated for the period starting on the day the application was received and ending on 31 December (inclusive) in that financial year, to be paid within 30 days of approval of the application; and

(b)                   the second instalment is the remaining amount of the CAPS payment, to be paid on or after 1 January but no later than 31 January in the financial year.

(4)        If an application under section 5 is received after 31 December in the financial year and is approved, the CAPS payment for that financial year is the amount calculated in accordance with 9(2), to be paid within 30 days of approval of the application.

(5)        However, despite anything in this Scheme, a second instalment must not be paid if the person’s participation has ceased to have effect before January in the financial year.

12.                  Payment to transferred person

(1)        This section applies to a person who is a participating person because of item 3 of the Amendment Act (transferred person).

(2)        The transferred person is entitled to the CAPS payment specified in subsection 9(1):

(a)                    for the 2010-11 financial year;

(b)                   and each subsequent financial year as long as the person’s participation has not ceased on a date before 1 July of that financial year.

(3)        For the financial year beginning on 1 July 2010, the Medicare Australia CEO must:

(a)                    make the CAPS payment for the person no later than 30 days after receiving the completed transfer form (transfer form) mentioned in item 3 of the Amendment Act; or

(b)                   if the person elects to receive the CAPS payment in two instalments, pay half the CAPS payment no later than 30 days after receiving the transfer form and half after 1 January 2011 but no later than 31 January 2011.

(4)        For a financial year after 30 June 2011, the CAPS payment for the person must be paid no later than 31 July in that financial year or, if the person has elected to receive the CAPS payment in two instalments, in the manner specified in paragraph 11(2).

(5)        If the person gives the transfer form to the Medicare Australia CEO before 1 July 2010, the form is taken to have been provided on 1 July 2010.

13.                  Payment to approved person

(1)        This section applies to a person who is a participating person because of an approval under section 5 of this Scheme (approved person).

(2)        The approved person is entitled to:

(a)                    the CAPS payment specified in subsection 9(1)or 9(2), whichever applies in the circumstances, in the financial year in which the application is approved; and

(b)                   the CAPS payment specified in subsection 9(1) in each subsequent financial year as long as the person’s participation has not ceased on a date before 1 July of that financial year.

(3)        The Medicare Australia CEO must make a CAPS payment for the approved person:

(a)                    if the person is a participating person on 1 July in the financial year:

(i)                      by 30 July in the financial year; or

(ii)                     if the payment is by instalments, in the manner specified in subsection 11(2); or

(b)                   if an application under section 5 is received after 1 July but before 31 December in the financial year and is approved:

(i)                      within 30 days of approving the application; or

(ii)                     if the payment is by instalments, in the manner specified in subsection 11(3);or

(c)                    if an application under section 5 is received after 31 December in the financial year and is approved—within 30 days of approving the application.

14.                  Notification of details of payments

(1)        The Medicare Australia CEO, as soon as practicable after making a CAPS payment, must give a written statement containing details about the payment to:

(a)                    the participating person or his or her correspondence recipient; and

(b)                   if the payment was made to an organisation─the organisation.

Part 4        Representatives and organisations

15.                  Interpretation

(1)        In this part:

assisted person means:

(a)                    a person applying to participate in this Scheme; or

(b)                   a participating person,

who is unable to act on his or her own behalf because of a physical or mental impairment.

16.                  Ceasing representation of a person

In this Part:

(a)                    if a person is recognised as representing another person because of a particular status under the social security law or veterans’ entitlements law, and the person ceases to hold that status, the person’s representation of the other person under this Scheme is also taken to cease;

(b)                   if a person may authorise, in accordance with this Part, another to do something, the person may also revoke the authorisation by notice in writing to the Medicare Australia CEO;

(c)                    if a person is authorised, in accordance with this Part, to do something and wishes to end the arrangement, the person may cease the arrangement by notice in writing to the Medicare Australia CEO.

17.                  Authorised representative

(1)       This section applies to an assisted person who does not have a legal representative.

(2)       The assisted person may be represented for the purposes of this Scheme, other than to receive payments, by one of the following, subject to subsection (3):

(a)                    the assisted person’s Centrelink correspondence nominee, as recognised by Centrelink for the purposes of the social security law (see Part 3A of the Social Security (Administration) Act 1999); or

(b)                   the assisted person’s Department of Veterans’ Affairs (DVA) trustee, as recognised by DVA for the purposes of veterans' entitlements (see the Veterans’ Entitlements Act 1986); or

(c)                    if the person does not have a representative mentioned in paragraph (a) or (b)—a responsible person approved as an authorised representative under section 20.

(3)        A person mentioned in subsection (2) who signs the application form for an assisted person, or nominates him or herself, in the approved form, after the application has been made, as the person authorised to represent the assisted person is taken to be the assisted person’s authorised representative.

(4)        An authorised representative must act in the interests of the assisted person at all times.

18.                  Correspondence recipient

An applicant, participating person or an assisted person’s legal representative or authorised representative may authorise, in the approved form, another person (correspondence recipient) to receive correspondence under this Scheme for the applicant or participating person.

19.                  Authorised payment recipient

(1)        One of the following people may receive payments as agent for a participating person if the conditions mentioned in subsection (2) are satisfied:

(a)                    the person recognised as the participating person's payment nominee for the purposes of the social security law; or

(b)                   the person recognised as the participating person's trustee or agent for the purposes of veterans' entitlements; or

(c)                    a responsible person approved as an authorised payment recipient under section 20; or

(d)                   an organisation authorised in accordance with subsection 21(2).

(2)        The conditions are:

(a)                    the person who is to receive the payments as agent for the participating person has been notified to the Medicare Australia CEO, in the approved form, that that person is to receive the payments; and

(b)                   if the applicant or participating person has a legal representative—the Medicare Australia CEO has not been notified by the legal representative that the CAPS payments are to be made to another person in accordance with this Scheme.

(3)        The person who is to receive the payments as agent for the participating person is the authorised payment recipient of the participating person.

20.                  Responsible person for a participating person

(1)        The Secretary may approve an individual to represent an assisted person or a minor:

(a)                    as an authorised representative to act for the person; or

(b)                   as an authorised payment recipient to receive payments as agent of the person; or

(a)                    as both (a) and (b).

(2)        However, the Secretary must not approve an individual unless the Secretary is satisfied that:

(b)                   if the assisted person has a legal representative, or representation by a person referred to in paragraph 17(2)(a) or (b) or 19(1)(a) or (b)—the representative does not oppose the approval; and

(a)                    the individual provides care or assistance to the person; and

(b)                   the arrangement for the receipt of CAPS payments is for the benefit of the person; and

(c)                    the individual seeking approval will use the funds only for the purpose for which they are provided.

(3)        The Secretary may revoke an approval if satisfied that it is appropriate to do so in the circumstances, having regard to the matters mentioned in this section.

21.                  Organisations authorised to receive CAPS payments

(1)        In paragraphs (4)(c), (d), (e) and (f) and subsections (5) and (6), a reference to a “participating person” includes a former participating person and, where the context permits, an authorised representative or correspondence nominee.

(2)        An applicant, participating person, or assisted person’s legal representative, authorised representative or authorised payment recipient, other than an organisation, may authorise, in the approved form, an organisation to receive CAPS payments, or instalments of CAPS payments, as the authorised payment recipient for a person entitled to the payment.

(3)        If the organisation agrees to receive the CAPS payments as agent, the organisation must provide details to the Medicare CEO for the payments in the approved form.

(4)        The organisation must comply with the following obligations:

(a)                    assist the participating person to obtain continence aids that are appropriate to his or her needs; and

(b)                   assist the participating person to use the CAPS payment as a contribution towards to the cost of purchasing continence aids; and

(c)                    inform the participating person of any unused CAPS payment amount 30 days before the end of the financial year to which the payment relates; and

(d)                   refund to the estate of a participating person who has died any unused portion of a CAPS payment; and

(e)                    refund to the participating person any unused portion of a CAPS payment if notified, in writing, that:

(i)                      the person has ceased to  meet the eligibility criteria; or

(ii)                     the person wishes to terminate the payment arrangement with the organisation; and

(f)                     refund to the participating person any unused portion of a CAPS payment if the participating person was not entitled to the payment at the time it was made; and

(g)                    inform the Medicare Australia CEO promptly on becoming aware that the participating person does not meet the eligibility criteria.

(5)        An organisation which receives a CAPS payment as agent for a participating person must maintain records in a collated and accessible form containing details of the amounts received, the date received and how the amount was used.

(6)        An organisation must provide details on the use of a CAPS payment if requested to do so by the participating person or his or her authorised representative.

(7)        The Secretary may direct, in writing, the Medicare Australia CEO to decline to make a CAPS payment to an organisation if the Secretary is satisfied that the arrangement for the payment:

(a)                    is not operating to the benefit of the participating person; or

(b)                   the organisation has not complied with an obligation imposed by this Scheme in respect of any participating person.

(8)        If a direction is given under subsection (7):

(a)                    the Medicare Australia CEO must comply with the direction; and

(b)                   the Secretary must inform the participating person and the organisation in writing that the organisation is no longer able to act as an authorised payment recipient.

Part 5        Miscellaneous

22.                  Debts

If a participating person or former participating person has received, either directly or through an agent, a CAPS payment to which the person was not entitled, the amount paid is a debt due to the Commonwealth, recoverable by the Medicare Australia CEO.

23.                  Investigations

The Medicare Australia CEO may conduct investigations, as he or she thinks appropriate, in order to ensure that an applicant or a participating person meets the eligibility criteria.

24.                  Review of decisions

(1)        For sections 14 and 15 of the Act, a person aggrieved by a decision under section 5 or 7 of this Scheme may apply, in the way set out in subsection (2), to the Medicare Australia CEO for review of the decision.

(2)        The application for review must:

(a)                    be made by written notice given to the Medicare Australia CEO within 28 days, or such longer period as the Medicare Australia CEO allows, after the day on which the person received notice of the decision; and

(b)                   set out the reasons for making the request.

Note:  Sections 14 and 15 of the Act provide for the reconsideration of decisions by the Medicare Australia CEO and review of such decisions by the Administrative Appeals Tribunal.

 

 

 


Schedule

 

Part 1 - Eligible neurological condition

Category 1

SPINA BIFIDA and SYRINGOMYELIA

 

Arnold-Chiari Syndrome

 

Arthrogryposis

 

Caudal Regression Syndrome

 

Developmental Cord Disorder

 

Holoprosencephaly

 

Malformation of Spinal Cord

 

Sacral Agenesis

 

Spinal Agenesis

 

Spinal Cord Congenital Abnormality

 

Spinal Dysraphism

 

Spinal Hemangioma

 

Vater Syndrome/Vacterl Syndrome

 

 

Category 2

CEREBRAL PALSY

 

Dystonic Cerebral Palsy

 

Hereditary Spastic Paralysis

 

Spastic Quadriplegia

 

 

Category 3

INTELLECTUAL DISABILITY

 

2-Hydroxyglutaric Aciduria

 

Agenesis of Corpus Callosum

 

Angelman Syndrome

 

Apert Syndrome

 

ATRX Syndrome

 

Bardot Biedl Syndrome

 

Batten Disease

 

Beare-Stevenson Syndrome

 

Cats Cry Syndrome/Cri Du Chat Syndrome

 

Cerebral Migration Disorders

 

Charge Syndrome

 

Chime Syndrome

 

Chromosomal Abnormalities/Disorders

 

Chromosome 1 Deletion

 

Chromosome 13q Deletion Syndrome

 

Chromosome 15q Duplication Syndrome

 

Chromosome 18q Deletion Syndrome

 

Chromosome 1p36 Deletion Syndrome/Mono 1p36

 

Chromosome 22 Ring

 

Chromosome 2q Deletion Syndrome

 

Chromosome 9p Deletion Syndrome

 

Chromosome 9q Deletion Syndrome

 

Chromosome Xp Duplication

 

Cockayne Syndrome

 

Coffin-Lowry Syndrome

 

Cognitive Impairment

 

Cohen Syndrome

 

Congenital Hydrocephalus

 

Congenital Neurological Infections

 

Cornelia de Lange Syndrome

 

Costello Syndrome

 

Cowden Disease

 

Developmental Delay

 

Developmental Delay associated with Autism, Autism Spectrum Disorder and Aspergers Syndrome

 

Down Syndrome/Trisomy 21

 

Dravet Syndrome

 

Edwards Syndrome/Trisomy 18

 

Fragile X Syndrome

 

Fumarase Deficiency

 

GLUT1-DS Condition

 

Glutaric Aciduria Type 1

 

Goldenhar’s Syndrome

 

Hunter Syndrome

 

Hurler-Scheie Syndrome

 

Hypomyelination

 

Incomplete Corpus Callosum/Aicardi Syndrome

 

Inversion Duplication of Chromosome 8

 

Jacobsen Syndrome/11q Chromosome Deletion

 

Joubert Syndrome

 

Kabuki Syndrome

 

Langer-Gideon Syndrome

 

Lawrence Moon Biedel Syndrome

 

Lennox-Gastaut Syndrome

 

Lesch-Nyhan Syndrome

 

Lissencephaly

 

Lowe Syndrome

 

Mannosidosis

 

Maple Syrup Urine Disease

 

Meningitis

 

Menkes Syndrome

 

Microcephaly

 

Mitochondrial Deficiency

 

Mowat-Wilson Syndrome

 

Mucolipidosis IV

 

Myotonic Dystrophy (Type 1)

 

Neonatal Hypoxia

 

Neonatal Onset Multi-system Inflammatory Disease

 

Normal Pressure Hydrocephalus

 

OHDO Syndrome

 

Opitz Trigonocephaly Syndrome

 

Ohtahara Syndrome

 

Ouvrier Syndrome

 

Pallister-Killian Mosaic Syndrome

 

Periventricular Leukomalacia

 

Peroxisome Biogenesis Disorder

 

Phelan McDermid Syndrome/22q 13 Deletion Syndrome

 

Phenylketonuria

 

Polymicrogyria

 

Pontocerebellar Hypoplasia

 

Prader-Willi Syndrome

 

Pyruvate Dehydrogenase Deficiency/Leigh's Disease

 

Rare Congenital Neurological Syndromes and Conditions

 

Rasmussen's Disease

 

Rett Syndrome

 

Rubinstein-Taybi Syndrome

 

Schizencephaly

 

Sensory Integration Disorder/Dysfunction

 

Smith-Lemli-Opitz Syndrome

 

Smith-Magenis Syndrome

 

Sotos Syndrome

 

Sturge-Weber Syndrome

 

Subcortical Band Heterotopia

 

Translocation of Chromosome 2

 

Translocation Trisomy 5/18

 

Trichothiodystrophy

 

Trisomy 10

 

Trisomy 13

 

Trisomy 20p

 

Trisomy 47

 

Trisomy 4p

 

Trisomy 9

 

Tuberous Sclerosis

 

Turner Syndrome

 

Urea Cycle Defect

 

Valproate Embryopathy

 

Velocardiofacial Syndrome

 

West Syndrome

 

Williams Syndrome

 

Wolf-Hirschhorn Syndrome

 

X-Linked Adrenoleukodystrophy

 

Young-Simpson Syndrome

 

 

Category 4

PARAPLEGIA and QUADRIPLEGIA

 

Paraparesis

 

Spinal Cord Compression

 

Spinal Cord Infarction

 

Spinal Damage

 

Syringomyelia

 

Tetraplegia

 

Transverse Myelitis

 

 

Category 5

ACQUIRED NEUROLOGICAL CONDITIONS

 

Acquired Brain Injury

 

Adhesive Arachnoiditis

 

Alcoholic Encephalopathy

 

Alzheimer's Disease

 

Arachnoiditis

 

Ascending Polyneuropathy

 

Astrocytoma

 

Autonomic Neuropathy Disease

 

Basal Ganglia Infarction

 

Benign Meningioma

 

Brown-Sequard Syndrome

 

Cauda Equina Lesion

 

Cerebral Abscess (Cryptococcus)

 

Cerebral Aneurysm

 

Cerebral Anoxia

 

Cerebral Toxoplasmosis

 

Cerebral Tumour

 

Cerebrovascular Disease

 

Chronic Hypoxia

 

Chronic Inflammatory Demyelination Polyneuropathy (CIDP)

 

Cortical-Basal Ganglionic Degeneration

 

Dementia

 

Developmental/Motor Dyspraxia

 

Diabetic Autonomic Neuropathy

 

Diabetic Neuropathic Bladder

 

Dorsal Pontine Band Syndrome

 

Encephalitis

 

Ependymoma

 

Epilepsy

 

Focal Cerebral Degeneration

 

Glioblastoma Multiforme

 

Glioblastoma of Spine

 

Hepatic Encephalopathy

 

Hydrocephalus

 

Hypoxic Brain Damage

 

Inoperable Neurogenic Incontinence

 

Intracerebral Haemorrhage

 

Korsakoff’s Syndrome

 

Leuco Posterior Encephalopathy

 

Lewi Body Disease

 

Macroencephaly

 

Malignant Meningioma

 

Metastatic Carcinoma with Neurological Syndrome

 

Multiple Systems Atrophy

 

Myopathy

 

Nemaline Myopathy

 

Oligodendroglioma

 

Pachymeningitis

 

Picks Disease

 

Pilocytic Astrocytoma

 

Poliomyelitis

 

Polymyoneuropathy

 

Primary Dystonia (case by case)

 

Progressive Systemic Sclerosis

 

Sacral Neuroplexy

 

Sacral Plexopathy

 

Schizophrenia (Catatonic)

 

Spinal Canal Disease

 

Spinal Chordoma

 

Spinal Ependymoma

 

Spinal Sacral Chordoma

 

Spinal Tumour

 

Stroke/Cerebrovascular Accident (CVA)

 

Subarachnoid Haemorrhage

 

Subdural Haematoma

 

Vascular Dementia

 

 

Category 6

DEGENERATIVE NEUROLOGICAL DISEASES

 

Alexander Disease

 

Amyotrophic Lateral Sclerosis

 

Ataxia Telangiectasia

 

Cauda Equina Syndrome

 

Cervical Canal Stenosis

 

Cervical Myelopathy

 

Creutzfeldt-Jakob Disease (CJD)

 

Cytochrome C Oxidase Deficiency

 

Dejerine-Sottas Disease

 

Demyelinating Neuropathy

 

Demyelination of White Matter

 

Fahr's Disease

 

Friedreich’s Ataxia

 

Guillain Barre Syndrome

 

Huntington Chorea/Disease

 

Hypoxic Ischaemic Encephalopathy

 

Idiopathic Axonal Neuropathy

 

Kugelberg-Welander Syndrome

 

Machado Joseph Disease

 

Metachromatic Leukodystrophy

 

Mitochondrial Myopathy with Encephalopathy

 

Morquio Syndrome

 

Motor Neurone Disease

 

Multiple Sclerosis

 

Muscular Dystrophy

 

Myoneural Disorders

 

Neuroaxonal Dystrophy

 

Neurofibromatosis NF

 

Neurogenic Bowel

 

Niemann-Pick Disease Type C

 

Pallister-Hall Syndrome

 

Parkinson Disease

 

Parkinsonism

 

PEHO Syndrome (Progressive encephalopathy with oedema, hypsarrhythmia and optic atrophy)

 

Pelizaeus Merzbacher Disease

 

Primary Lateral Sclerosis

 

Progressive Supranuclear Palsy/Steele Richardson Syndrome

 

Sanfilippo Syndrome

 

Sarcoidosis of the Brain

 

Shy-Drager Syndrome

 

Spinal Cord Syndrome

 

Spinal Degeneration

 

Spinal Muscular Atrophy Type 1

 

Spinal Muscular Atrophy Type 2

 

Spinocerebellar Degeneration

 

Stiff-Mans Syndrome

 

Striato-Nigral Degeneration

 

Vascular Myelopathy

 

Wallerian Degeneration of White Matter

 

Wilson's Disease

 

 

Category 7

BLADDER (BOWEL) INNERVATION DISORDERS

 

Atonic Bladder/Hypotonic Bladder

 

Bladder Exstrophy

 

Bladder Innervation Urgency

 

Cloacal Exstrophy

 

Cystocele (not suitable for surgery)

 

Dystonic Bladder

 

Ectopia Vesica

 

Hirschsprung's Disease

 

Linear Sebaceous Nevus Genetic

 

Myasthenia Gravis

 

Neurogenic Bladder

 

Neuronal Intestinal Dysplasia

 

Neuropathic Bladder

 

Post Bladder Surgery

 

Prostatectomy with nerve removal

 

Prune Belly Syndrome

 

Pudendal Nerve Palsy

 

Radical Prostatectomy

 

Schmidli Autonomic Neuropathy

 

Smooth Muscle Myopathy

 

Sphincter Deficiency

 

Spinal Stenosis

 

Part 2 - Eligible other condition

Code 8

OTHER

 

Anal Carcinoma

 

Anal Fistula

 

Anorectal Malformation

 

Anterior Prolapse

 

Bilateral Nephrostomy Tubes

 

Bladder Cancer

 

Bladder Instability

 

Bladder Muscle Dysfunction

 

Bladder Neck Dysfunction

 

Bladder Neck Fibrosis

 

Bladder Prolapse

 

Bowel Cancer

 

Bowel Prolapse

 

Cervical Cancer

 

Chronic Urinary Retention

 

Congenital Epispadias

 

Detrusor Instability

 

Detrusor Overactivity

 

Enterocutaneous Fistula

 

Hypertonic Bladder

 

Imperforate Anus

 

Irradiated Rectum/Radiation Proctitis

 

Posterior Urethral Valve Syndrome

 

Prostate Cancer

 

Prostate Disease

 

Rectal Prolapse

 

Rectal Ulcer Syndrome

 

Severe Ulcerative Proctitis/Ulcerative Colitis

 

Spastic Bladder

 

TURP

 

Urethral Stenosis

 

Urinary Fistula

 

Uterine Cancer

 

Uterine Prolapse

 

Vaginal Prolapse

 

Vesico-Vaginal Fistula

 

Vulva Cancer